S&P revises Concentra view to stable

S&P said it raised its outlook on Concentra Inc. to stable from negative on better-than-expected performance. The company’s issuer credit rating was affirmed at B+.

The stable outlook reflects S&P’s view that Concentra's growth rate, inclusive of small tuck-in acquisitions and de novos, will be slightly better than the industry average, with improving EBITDA margins and discretionary cash flow generation of about $90 million, S&P said in a news release.

The company “has performed slightly better than our expectations following its February 2018 acquisition of U.S. HealthWorks, and we expect further improvement this year,” S&P said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.